207 related articles for article (PubMed ID: 18684955)
1. Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection.
Bixby LM; Tarleton RL
J Immunol; 2008 Aug; 181(4):2644-50. PubMed ID: 18684955
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection.
Martin DL; Tarleton RL
J Immunol; 2005 Feb; 174(3):1594-601. PubMed ID: 15661921
[TBL] [Abstract][Full Text] [Related]
3. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.
Bachmann MF; Wolint P; Schwarz K; Jäger P; Oxenius A
J Immunol; 2005 Oct; 175(7):4686-96. PubMed ID: 16177116
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
[TBL] [Abstract][Full Text] [Related]
5. Viral FLIP impairs survival of activated T cells and generation of CD8+ T cell memory.
Wu Z; Roberts M; Porter M; Walker F; Wherry EJ; Kelly J; Gadina M; Silva EM; DosReis GA; Lopes MF; O'Shea J; Leonard WJ; Ahmed R; Siegel RM
J Immunol; 2004 May; 172(10):6313-23. PubMed ID: 15128821
[TBL] [Abstract][Full Text] [Related]
6. Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.
Rigato PO; de Alencar BC; de Vasconcelos JR; Dominguez MR; Araújo AF; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
Infect Immun; 2011 May; 79(5):2120-30. PubMed ID: 21357719
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.
Bustamante JM; Bixby LM; Tarleton RL
Nat Med; 2008 May; 14(5):542-50. PubMed ID: 18425131
[TBL] [Abstract][Full Text] [Related]
8. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells.
Berenzon D; Schwenk RJ; Letellier L; Guebre-Xabier M; Williams J; Krzych U
J Immunol; 2003 Aug; 171(4):2024-34. PubMed ID: 12902507
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.
Takayama E; Ono T; Carnero E; Umemoto S; Yamaguchi Y; Kanayama A; Oguma T; Takashima Y; Tadakuma T; García-Sastre A; Miyahira Y
Int J Parasitol; 2010 Nov; 40(13):1549-61. PubMed ID: 20620143
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection.
Leavey JK; Tarleton RL
J Immunol; 2003 Mar; 170(5):2264-8. PubMed ID: 12594245
[TBL] [Abstract][Full Text] [Related]
11. IL-10 participates in the expansion and functional activation of CD8
Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
[TBL] [Abstract][Full Text] [Related]
12. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
Martin D; Tarleton R
Immunol Rev; 2004 Oct; 201():304-17. PubMed ID: 15361249
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients.
Albareda MC; Laucella SA; Alvarez MG; Armenti AH; Bertochi G; Tarleton RL; Postan M
Int Immunol; 2006 Mar; 18(3):465-71. PubMed ID: 16431876
[TBL] [Abstract][Full Text] [Related]
14. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
Chowdhury IH; Lokugamage N; Garg NJ
Front Immunol; 2020; 11():595039. PubMed ID: 33414785
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim.
Kurtulus S; Tripathi P; Moreno-Fernandez ME; Sholl A; Katz JD; Grimes HL; Hildeman DA
J Immunol; 2011 May; 186(10):5729-37. PubMed ID: 21451108
[TBL] [Abstract][Full Text] [Related]
17. Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During
Ambrosio LF; Insfran C; Volpini X; Acosta Rodriguez E; Serra HM; Quintana FJ; Cervi L; Motrán CC
Front Immunol; 2019; 10():631. PubMed ID: 30984194
[TBL] [Abstract][Full Text] [Related]
18. The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development.
Castro I; Yu A; Dee MJ; Malek TR
J Immunol; 2011 Nov; 187(10):5170-82. PubMed ID: 21984699
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.
Rosenberg CS; Martin DL; Tarleton RL
J Immunol; 2010 Jul; 185(1):560-8. PubMed ID: 20530265
[TBL] [Abstract][Full Text] [Related]
20. Highly competent, non-exhausted CD8+ T cells continue to tightly control pathogen load throughout chronic Trypanosoma cruzi infection.
Pack AD; Collins MH; Rosenberg CS; Tarleton RL
PLoS Pathog; 2018 Nov; 14(11):e1007410. PubMed ID: 30419010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
